P17.89 EFFECTS OF GLIOBLASTOMA FIRST-LINE TRIALS ON TIME DELAY TO INITIATION OF TREATMENT, SIGNS OF EARLY TUMOR PROGRESSION AND PROGRESSION-FREE SURVIVAL

nork Sefranek, D., Wendl, C., Hutterer, M., Hau, P., Uhl, M.
Argitaratua 2014

How we treat medulloblastoma in adults

nork Franceschi, E., Seidel, C., Sahm, F., Pajtler, K.W., Hau, P.
Argitaratua izan da ESMO Open (2021)

The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-β2

nork Arslan, F, Bosserhoff, A-K, Nickl-Jockschat, T, Doerfelt, A, Bogdahn, U, Hau, P
Argitaratua 2007

OS9.8 Genomic landscape of medulloblastoma in adults

nork Goschzik, T, zur Mühlen, A, Dörner, E, Waha, A, Friedrich, C, Hau, P, Pietsch, T
Argitaratua izan da Neuro Oncol (2019)

P01.11 ATF4 AS A MEDIATOR OF RESISTANCE TO TARGETED THERAPY IN HIGH-GRADE GLIOMAS

nork Moeckel, S., Neyns, B., Pan, E., Riemenschneider, M., Bosserhoff, A., Vollmann-Zwerenz, A., Hau, P.
Argitaratua 2014

Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis

nork Kleiter, I, Hans, V, Schuierer, G, Marienhagen, J, Hau, P, Schutz, H, Bogdahn, U, Steinbrecher, A
Argitaratua 2004

OS7.7 Feasibility and toxicity of concomitant radiochemotherapy with vincristine in adult patients with medulloblastoma - results from the NOA-07 trial

nork Seidel, C., Reimers, C., Beier, D., Pietsch, T., Warmuth-Metz, M., Bogdahn, U., Kortmann, R., Hau, P.
Argitaratua izan da Neuro Oncol (2016)

P17.39 TURN OLD INTO NEW: METFORMIN AS ANTINEOPLASTIC AGENT IN GLIOBLASTOMA

nork Seliger, C., Renner, K., Kreutz, M., Meyer, A., Jachnik, B., Bogdahn, U., Vollmann-Zwerenz, A., Hau, P.
Argitaratua 2014

OS02.1 Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma - the NOA-07 trial

nork Beier, D., Proescholdt, M., Reinert, C., Hattingen, E., Seidel, C., Dirven, L., Lürding, R., Pfister, S., Pietsch, T., Hau, P.
Argitaratua izan da Neuro Oncol (2017)

P01.37 Impact of C/EBPβ isoforms on brain tumor initiating cells

nork Vollmann-Zwerenz, A., Sponton, S., Jachnik, B., Weigell, P., Lorenz, J., Schulze, M., Bogdahn, U., Riemenschneider, M. J., Hau, P.
Argitaratua izan da Neuro Oncol (2017)

P09.20 Effect of age on outcome in the GLARIUS trial

nork Kebir, S., Schaefer, N., Hattingen, E., Steinbach, J., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Herrlinger, U., Glas, M.
Argitaratua izan da Neuro Oncol (2017)

Low Entomological Impact of New Water Supply Infrastructure in Southern Vietnam, with Reference to Dengue Vectors

nork Tran, Hau P., Huynh, Trang T. T., Nguyen, Yen T., Kutcher, Simon, O'Rourke, Peter, Marquart, Louise, Ryan, Peter A., Kay, Brian H.
Argitaratua 2012

P16.11 Complete resection is not associated with improved survival in MGMT non-methylated glioblastoma. Results from the GLARIUS trial

nork Kebir, S., Stummer, W., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Vatter, H., Herrlinger, U., Glas, M.
Argitaratua izan da Neuro Oncol (2017)

P03.02 IN SITU ORGANOTYPIC SLICE CULTURE MIGRATION MODEL TO DISSECT INFILTRATIVE FROM STATIONARY HUMAN BRAIN TUMOR INITIATING CELLS

nork Gawrisch, V., Patwary, N., Rüttgers, M., Kerkhoff, E., Riemenschneider, M.J., Bogdahn, U., Vollmann-Zwerenz, A., Klein, C.A., Hau, P.
Argitaratua 2014

O10.04 THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL...

nork Herrlinger, U., Schäfer, N., Steinbach, J.P., Weyerbrock, A., Hau, P., Goldbrunner, R., Leutgeb, B., Urbach, H., Stummer, W., Glas, M.
Argitaratua 2014

P01.060 PriCoTTF: a phase I/II trial of Tumor Treating Fields prior and concomitant to radiotherapy in newly diagnosed glioblastoma

nork Glas, M, Scheffler, B, Lazaridis, L, Herrlinger, U, Pierscianek, D, Sure, U, Pröscholdt, M, Hau, P, Hense, J, Kleinschnitz, C, Grosu, A, Stuschke, M, Kebir, S
Argitaratua izan da Neuro Oncol (2018)

OS06.3 Characterisation of human brain tumour initiating cells leading invasion

nork Leidgens, V. J., Alieva, M., Lu, X., Patwary, N., Kerkhoff, E., Proescholdt, M. J. M., Vollmann-Zwerenz, A., van Rheenen, J., Klein, C. A., Hau, P.
Argitaratua izan da Neuro Oncol (2017)

Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype

nork Keil, V.C., Warmuth-Metz, M., Reh, C., Enkirch, S.J., Reinert, C., Beier, D., Jones, D.T.W., Pietsch, T., Schild, H.H., Hattingen, E., Hau, P.
Argitaratua izan da AJNR Am J Neuroradiol (2017)

Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

nork Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N.K., Mahapatra, A.K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., Poverennova, I., Zaaroor, M., Jachimczak, P., Ludwig, S., Schmaus, S., Heinrichs, H., Schlingensiepen, K.-H.
Argitaratua 2011

Viral load testing to monitor the HIV epidemic among PWID in Vietnam

nork Khuu, Nghia V., Nguyen, Thuong V., Tran, Hau P., Nguyen, Phuc D., Vu, Thinh X., Tran, Ton, Vu, Diep T., Le, Giang T., Bui, Duc H., Thanh, Duong C., Tieu, Van T., Nguyen, Linh N., Phan, Huong T., Abdul-Quader, Abu
Argitaratua izan da Online J Public Health Inform (2018)